Myers Scott Dunseth

CIK 00013562569 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001356256

Recent Transactions

50 trades

Purchase
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-08-22$10.82/sh+3,800→ 35,004 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-06-17+57,603→ 338,795 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-06-11+5,758→ 31,204 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2025-06-11+28,500→ 28,500 total
Purchase
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-04-30$1.40/sh+21,000→ 281,192 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-11-13+260,192→ 260,192 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2024-05-23+22,500→ 22,500 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-05-23+5,357→ 25,446 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−4,600→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−2,033→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−22,665→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-01-01+2,048→ 22,666 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-11-27+5,000→ 20,618 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13−20,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13−20,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13$0.93/sh−87,500→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-10-01+5,797→ 15,618 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-07-01+35,634→ 98,215 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2023-06-22+46,000→ 46,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-05-26+5,357→ 20,089 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2023-05-26+22,500→ 22,500 total
Purchase
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2023-04-12$25.37/sh+4,000→ 259,500 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-04-01+34,925→ 62,581 total
Purchase
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2023-03-13$29.15/sh+5,500→ 255,500 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2023-02-06+250,000→ 250,000 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2023-02-06+1,000,000→ 1,000,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-01-02+87,500→ 87,500 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2022-06-22+20,334→ 20,334 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2022-05-26+4,018→ 4,018 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2022-05-26+16,875→ 16,875 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2022-01-03+40,000→ 40,000 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−67,000→ 0 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-10-25+10,167→ 10,167 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2021-10-19+10,714→ 10,714 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2021-10-19+45,000→ 45,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-05-03+67,000→ 67,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2021-03-30+40,000→ 40,000 total
Disposition to Issuer
AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2020-11-16−1,000,000→ 0 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2020-06-19+20,000→ 20,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2020-05-28+10,167→ 10,167 total
Award
AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2020-04-28+1,000,000→ 1,000,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2019-12-23$1.46/sh+39,409→ 80,845 total
Award
Cartesian Therapeutics, Inc.$RNAC
Warrants
2019-12-23$0.13/sh+19,704→ 19,704 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2019-08-20$1.81/sh+41,436→ 41,436 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2019-06-14+20,000→ 20,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2019-06-03+10,167→ 10,167 total

Companies

Recent Filings

Address

C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720

EMERYVILLE, CA, 94608

View on SEC.gov